Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis

Objective To assess pathological characteristics, clinical features and outcomes of patients diagnosed with peripheral zone (PZ) and transition zone (TZ) prostate cancer after prostatectomy.Methods and analysis We systematically reviewed PubMed, EMBASE and MEDLINE. Primary endpoints were biochemical...

Full description

Saved in:
Bibliographic Details
Main Authors: Pedro Oliveira, Robert G Bristow, Ananya Choudhury, Ashwin Sachdeva, Noel Clarke, Hitesh Mistry, Amin Ali, Thiraviyam Elumalai, BhanuPrasad Venkatesulu, Lauren Hekman, Esther Baena
Format: Article
Language:English
Published: BMJ Publishing Group 2024-07-01
Series:BMJ Oncology
Online Access:https://bmjoncology.bmj.com/content/3/1/e000193.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832581832766390272
author Pedro Oliveira
Robert G Bristow
Ananya Choudhury
Ashwin Sachdeva
Noel Clarke
Hitesh Mistry
Amin Ali
Thiraviyam Elumalai
BhanuPrasad Venkatesulu
Lauren Hekman
Esther Baena
author_facet Pedro Oliveira
Robert G Bristow
Ananya Choudhury
Ashwin Sachdeva
Noel Clarke
Hitesh Mistry
Amin Ali
Thiraviyam Elumalai
BhanuPrasad Venkatesulu
Lauren Hekman
Esther Baena
author_sort Pedro Oliveira
collection DOAJ
description Objective To assess pathological characteristics, clinical features and outcomes of patients diagnosed with peripheral zone (PZ) and transition zone (TZ) prostate cancer after prostatectomy.Methods and analysis We systematically reviewed PubMed, EMBASE and MEDLINE. Primary endpoints were biochemical relapse-free survival (bRFS) and distant metastases rate; secondary endpoints included clinical and pathological features.Results Ten retrospective cohort studies were identified, six reported HRs for bRFS between PZ and TZ tumours. Patients with TZ tumours had significantly better bRFS (pooled HR 0.57 (0.47, 0.68)) than those with PZ tumours. Two studies reported a lower proportion of distant metastasis in patients diagnosed with TZ tumours compared with PZ tumours (1.5% vs 4.9% (median follow-up 7.0 years) and 0% vs 5% (median follow-up 7.8 years)). PZ tumours presented higher Gleason group and T staging more frequently, while TZ tumours were associated with higher prostate specific antigen levels at diagnosis.Conclusion PZ tumours were associated with poorer prognostic clinical features and outcomes. Despite adjusting for poor prognostic clinical features, PZ tumours consistently showed worse clinical outcomes than TZ tumours. Our systematic review underscores the need for further research comparing PZ and TZ prostate cancer to understand the underlying differences and refine clinical practice.
format Article
id doaj-art-d688267134774f6b9052fd06bfbc51fb
institution Kabale University
issn 2752-7948
language English
publishDate 2024-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Oncology
spelling doaj-art-d688267134774f6b9052fd06bfbc51fb2025-01-30T09:55:09ZengBMJ Publishing GroupBMJ Oncology2752-79482024-07-013110.1136/bmjonc-2023-000193Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysisPedro Oliveira0Robert G Bristow1Ananya Choudhury2Ashwin Sachdeva3Noel Clarke4Hitesh Mistry5Amin Ali6Thiraviyam Elumalai7BhanuPrasad Venkatesulu8Lauren Hekman9Esther Baena10Department of Pathology, The Christie Hospital NHS Trust, Manchester, UKTranslational Oncogenomics, Cancer Research UK Manchester Centre, The University of Manchester, Manchester, UKDivision of Cancer Sciences, University of Manchester, Manchester, UKDepartment of Surgery, The Christie Hospital NHS Trust, Manchester, UK5 The Christie NHS Foundation Trust, Manchester, Manchester, UKSchool of Health Sciences, The University of Manchester, Manchester, UKOncology Department, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UKOncology Department, Addenbrooke`s Hospital, Cambridge, UKRadiation Oncology Department, Loyola University Chicago, Chicago, Illinois, USADepartment of Urology, Loyola University Chicago, Chicago, Illinois, USAProstate Oncobiology, Cancer Research UK Manchester Centre, The University of Manchester, Manchester, UKObjective To assess pathological characteristics, clinical features and outcomes of patients diagnosed with peripheral zone (PZ) and transition zone (TZ) prostate cancer after prostatectomy.Methods and analysis We systematically reviewed PubMed, EMBASE and MEDLINE. Primary endpoints were biochemical relapse-free survival (bRFS) and distant metastases rate; secondary endpoints included clinical and pathological features.Results Ten retrospective cohort studies were identified, six reported HRs for bRFS between PZ and TZ tumours. Patients with TZ tumours had significantly better bRFS (pooled HR 0.57 (0.47, 0.68)) than those with PZ tumours. Two studies reported a lower proportion of distant metastasis in patients diagnosed with TZ tumours compared with PZ tumours (1.5% vs 4.9% (median follow-up 7.0 years) and 0% vs 5% (median follow-up 7.8 years)). PZ tumours presented higher Gleason group and T staging more frequently, while TZ tumours were associated with higher prostate specific antigen levels at diagnosis.Conclusion PZ tumours were associated with poorer prognostic clinical features and outcomes. Despite adjusting for poor prognostic clinical features, PZ tumours consistently showed worse clinical outcomes than TZ tumours. Our systematic review underscores the need for further research comparing PZ and TZ prostate cancer to understand the underlying differences and refine clinical practice.https://bmjoncology.bmj.com/content/3/1/e000193.full
spellingShingle Pedro Oliveira
Robert G Bristow
Ananya Choudhury
Ashwin Sachdeva
Noel Clarke
Hitesh Mistry
Amin Ali
Thiraviyam Elumalai
BhanuPrasad Venkatesulu
Lauren Hekman
Esther Baena
Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis
BMJ Oncology
title Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis
title_full Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis
title_fullStr Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis
title_full_unstemmed Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis
title_short Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis
title_sort tale of two zones investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta analysis
url https://bmjoncology.bmj.com/content/3/1/e000193.full
work_keys_str_mv AT pedrooliveira taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT robertgbristow taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT ananyachoudhury taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT ashwinsachdeva taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT noelclarke taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT hiteshmistry taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT aminali taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT thiraviyamelumalai taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT bhanuprasadvenkatesulu taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT laurenhekman taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis
AT estherbaena taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis